Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,106,000 | 13,421,000 | 8,829,000 | 4,332,000 | 12,059,000 |
| Depreciation Amortization | 1,098,000 | 820,000 | 542,000 | 269,000 | 1,050,000 |
| Income taxes - deferred | -393,000 | -442,000 | -260,000 | -121,000 | -236,000 |
| Accounts receivable | -1,397,000 | -1,610,000 | -810,000 | -348,000 | -2,578,000 |
| Accounts payable and accrued liabilities | 226,000 | 288,000 | 620,000 | 58,000 | -289,000 |
| Other Working Capital | 1,495,000 | 1,336,000 | 2,033,000 | 1,132,000 | -518,000 |
| Other Operating Activity | 2,115,000 | 1,642,000 | 405,000 | 379,000 | 3,330,000 |
| Operating Cash Flow | $21,250,000 | $15,455,000 | $11,359,000 | $5,701,000 | $12,818,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,728,000 | -9,456,000 | -5,556,000 | -2,175,000 | -1,248,000 |
| PPE Investments | -747,000 | -581,000 | -295,000 | -124,000 | -557,000 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -18,000 |
| Investing Cash Flow | $-12,475,000 | $-10,037,000 | $-5,851,000 | $-2,299,000 | $-1,823,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,686,000 | 10,502,000 | 508,000 | 154,000 | 10,475,000 |
| Debt Repayment | -997,000 | -763,000 | -650,000 | -199,000 | -4,805,000 |
| Common Stock Issued | 319,000 | 281,000 | 202,000 | 118,000 | 331,000 |
| Common Stock Repurchased | -10,002,000 | -6,951,000 | -3,901,000 | -3,001,000 | -5,349,000 |
| Dividend Paid | -1,874,000 | -1,260,000 | -633,000 | N/A | N/A |
| Other Financing Activity | -4,016,000 | -3,228,000 | -3,589,000 | 206,000 | -3,677,000 |
| Financing Cash Flow | $-5,884,000 | $-1,419,000 | $-8,063,000 | $-2,722,000 | $-3,025,000 |
| Exchange Rate Effect | -67,000 | -61,000 | -55,000 | -72,000 | -56,000 |
| Beginning Cash Position | 10,027,000 | 10,027,000 | 10,027,000 | 10,027,000 | 2,113,000 |
| End Cash Position | 12,851,000 | 13,965,000 | 7,417,000 | 10,635,000 | 10,027,000 |
| Net Cash Flow | $2,824,000 | $3,938,000 | $-2,610,000 | $608,000 | $7,914,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,250,000 | 15,455,000 | 11,359,000 | 5,701,000 | 12,818,000 |
| Capital Expenditure | -747,000 | -581,000 | -295,000 | -124,000 | -557,000 |
| Free Cash Flow | 20,503,000 | 14,874,000 | 11,064,000 | 5,577,000 | 12,261,000 |